Inactive Instrument

Insiders OptimizeRx Corporation Other OTC

Equities

OptimizeRx Corporation Announces Changes to its Board	Jan. 25	CI
Optimizerx Corporation to Change the Designation of Stephen L. Silvestro from Chief Commercial Officer to President	23-10-16	CI
OptimizeRx’s Karina Castagna Named to MM+M’s 40 Under 40 List of the Medical Marketing Industry’s Brightest Young Stars	23-02-09	AQ
Insider Buy: Optimizerx	22-08-23	MT
OptimizeRx’s Mike Rousselle Named One of 2022 PM360 ELITE 100	22-05-17	GL
Insider Sell: OptimizeRx	22-02-23	MT
OptimizeRx’s Mike Rousselle Named to MM+M’s 40 Under 40 List of the Medical Marketing Industry’s Brightest Young Stars	22-02-01	AQ
OptimizeRx Corporation Announces Executive Changes	21-12-22	CI
Insider Sell: OptimizeRx	21-12-21	MT
Insider Sell: OptimizeRX	21-11-17	MT
Insider Sell: Optimizerx	21-10-19	MT
Insider Sell: Optimizerx	21-10-19	MT
Insider Sell: Optimizerx	21-10-05	MT
Insider Sell: Optimizerx	21-10-05	MT
Top Midday Gainers	21-09-30	MT
OptimizeRx Corp. Appoints Edward Stelmakh as Chief Operations Officer, Effective October 11, 2021	21-09-30	CI
OptimizeRx : Hires Edward Stelmakh as CFO, COO	21-09-30	MT
OptimizeRx Corporation Appoints Edward Stelmakh as Chief Financial Officer	21-09-30	CI
OptimizeRx Appoints Edward Stelmakh as Chief Operations Officer	21-09-30	CI
Insider Sell: Optimizerx	21-09-29	MT

No results for this search